AMRIX
Active substance: cyclobenzaprine
CAPSULE, EXTENDED RELEASE · CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1
United StatesActive
Marketing holder: Cephalon, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CYCLOBENZAPRINE HYDROCHLORIDE · 15 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-38ad-70d4-bf7e-65fb0ac333ca;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2733-730d-9a07-52dacb8b84df,01a1208c-29c2-7acf-be5e-772ea9982755,01a1208c-29dc-78fa-ab02-1ba93ab55321,01a1208c-2cba-756a-8802-22b79d5806ea,01a1208c-2cfb-7b07-9a2e-90df98d8aa80;count=238 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63459-700
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 63459-700 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63459-700 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63459-700 · Verified 2026-10-09 · open in source